Patents by Inventor Gabriele Roidl

Gabriele Roidl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11852564
    Abstract: The invention concerns the field of container closure integrity (CCI) and the testing of CCI and relates to a device and a method for providing a displacement of a rubber stopper for leakage testing of a connection between the rubber stopper and a corresponding drug container which can be used for storing drugs under sterile conditions and which is closed by said rubber stopper.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: December 26, 2023
    Inventors: Martin Vogt, Roman Mathaes, Hanns-Christian Mahler, Atanas Koulov, Gabriele Roidl, Franziska Riesen Fuchs
  • Publication number: 20230134438
    Abstract: The invention concerns the field of container closure integrity (CCI) and the testing of CCI and relates to a device and a method for providing a displacement of a rubber stopper for leakage testing of a connection between the rubber stopper and a corresponding drug container which can be used for storing drugs under sterile conditions and which is closed by said rubber stopper.
    Type: Application
    Filed: November 10, 2022
    Publication date: May 4, 2023
    Inventors: Martin Vogt, Roman Mathaes, Hanns-Christian Mahler, Atanas Koulov, Gabriele Roidl, Franziska Riesen Fuchs
  • Patent number: 11499885
    Abstract: The invention concerns the field of container closure integrity (CCI) and the testing of CCI and relates to a device and a method for providing a displacement of a rubber stopper for leakage testing of a connection between the rubber stopper and a corresponding drug container which can be used for storing drugs under sterile conditions and which is closed by said rubber stopper.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: November 15, 2022
    Inventors: Martin Vogt, Roman Mathaes, Hanns-Christian Mahler, Atanas Koulov, Gabriele Roidl, Franziska Riesen Fuchs
  • Patent number: 11346742
    Abstract: The invention concerns the field of container closure integrity (CCI) and the testing of CCI and relates to a device and a method for leakage testing of a connection between a rubber stopper and a corresponding drug container which can be used for storing drugs under sterile conditions and which is closed by said rubber stopper.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: May 31, 2022
    Assignee: Lonza Ltd
    Inventors: Martin Vogt, Roman Mathaes, Hanns-Christian Mahler, Atanas Koulov, Gabriele Roidl, Franziska Riesen Fuchs
  • Publication number: 20220042873
    Abstract: The invention concerns the field of container closure integrity (CCI) and the testing of CCI and relates to a device and a method for providing a displacement of a rubber stopper for leakage testing of a connection between the rubber stopper and a corresponding drug container which can be used for storing drugs under sterile conditions and which is closed by said rubber stopper.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 10, 2022
    Inventors: Martin Vogt, Roman Mathaes, Hanns-Christian Mahler, Atanas Koulov, Gabriele Roidl, Franziska Riesen Fuchs
  • Publication number: 20210389206
    Abstract: The invention concerns the field of container closure integrity (CCI) and the testing of CCI and relates to a device and a method for leakage testing of a connection between a rubber stopper and a corresponding drug container which can be used for storing drugs under sterile conditions and which is closed by said rubber stopper.
    Type: Application
    Filed: November 22, 2019
    Publication date: December 16, 2021
    Inventors: Martin Vogt, Roman Mathaes, Hanns-Christian Mahler, Atanas Koulov, Gabriele Roidl, Franziska Riesen Fuchs
  • Patent number: 8178670
    Abstract: The present disclosure provides a method that efficiently produces (6R)-tetrahydrobiopterin of Formula I in high yield and purity. The method includes the step of hydrolyzing diacetylbiopterin to biopterin under basic conditions in a biphasic mixture comprising an organic phase and an aqueous phase. After substantially complete hydrolysis of diacetylbiopterin, the aqueous phase containing biopterin can be separated from the organic phase containing most of the organic impurities, which avoids the time-consuming step of isolating biopterin as a solid. The aqueous solution containing biopterin is stereoselectively hydrogenated to (6R)-tetrahydrobiopterin under basic conditions and high hydrogen pressure in the presence of a metal catalyst (e.g., a platinum catalyst). To improve the purification of an acid addition salt of (6R)-tetrahydrobiopterin (e.g., (6R)-tetrahydrobiopterin dihydrochloride), any residual salts (e.g.
    Type: Grant
    Filed: January 6, 2009
    Date of Patent: May 15, 2012
    Assignee: BioMarin Pharmaceutical Inc.
    Inventors: Mark Henderson, Steven Jungles, Gabriele Roidl, Robert Baffi, Adriano Indolese, Christian Müller, Philipp Schmidt, Stefan Kaiser
  • Publication number: 20090198055
    Abstract: The present disclosure provides a method that efficiently produces (6R)-tetrahydrobiopterin in high yield and purity. The method includes the step of hydrolyzing diacetylbiopterin to biopterin under basic conditions in a biphasic mixture comprising an organic phase and an aqueous phase. After substantially complete hydrolysis of diacetylbiopterin, the aqueous phase containing biopterin can be separated from the organic phase containing most of the organic impurities, which avoids the time-consuming step of isolating biopterin as a solid. The aqueous solution containing biopterin is stereoselectively hydrogenated to (6R)-tetrahydrobiopterin under basic conditions and high hydrogen pressure in the presence of a metal catalyst (e.g., a platinum catalyst). To improve the purification of an acid addition salt of (6R)-tetrahydrobiopterin (e.g., (6R)-tetrahydrobiopterin dihydrochloride), any residual salts (e.g.
    Type: Application
    Filed: January 6, 2009
    Publication date: August 6, 2009
    Applicant: BioMarin Pharmaceutical Inc.
    Inventors: Mark Henderson, Steven Jungles, Gabriele Roidl, Robert Baffi, Adriano Indolese, Christian Muller, Philipp Schmidt, Stefan Kaiser